DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 von O'Connor, J P B, Rose, C J, Jackson, A, Watson, Y, Cheung, S, Maders, F, Whitcher, B J, Roberts, C, Buonaccorsi, G A, Thompson, G, Clamp, A R, Jayson, G C, Parker, G J M

Volltext

Antiangiogenic drugs in ovarian cancer von Kumaran, G C, Jayson, G C, Clamp, A R

Volltext

Thrombosis in ovarian cancer: a case control study von Metcalf, R L, Fry, D J, Swindell, R, McGurk, A, Clamp, A R, Jayson, G C, Hasan, J

Volltext

A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer von Hall, M.R., Dehbi, H.-M., Banerjee, S., Lord, R., Clamp, A., Ledermann, J.A., Nicum, S., Lilleywhite, R., Bowen, R., Michael, A., Feeney, A., Glasspool, R., Hackshaw, A., Rustin, G.

Volltext

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer von Francis, K.E., Kim, S.I., Friedlander, M., Gebski, V., Ray-Coquard, I., Clamp, A., Penson, R.T., Oza, A., Perri, T., Huzarski, T., Martin-Lorente, C., Cecere, S.C., Colombo, N., Ataseven, B., Fujiwara, K., Sonke, G., Vergote, I., Pujade-Lauraine, E., Kim, J.-W., Lee, C.K.

Volltext

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer von McNeish, I.A., Ledermann, J.A., Webber, L., James, L., Kaye, S.B., Hall, M., Hall, G., Clamp, A., Earl, H., Banerjee, S., Kristeleit, R., Raja, F., Feeney, A., Lawrence, C., Dawson-Athey, L., Persic, M., Khan, I.

Volltext

Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903) von Friedlander, M., Benson, C., O'Connell, R.L., Reed, N., Clamp, A., Lord, R., Millan, D., Nottley, S., Amant, F., Steer, C., Anand, A., Mileshkin, L., Beale, P., Banerjee, S., Bradshaw, N., Kelly, C., Carty, K., Divers, L., Alexander, L., Edmondson, R.

Volltext

Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition von Sowerbutts, A. M., Lal, S., Sremanakova, J., Clamp, A. R., Jayson, G. C., Hardy, L., Sutton, E., Raftery, A.‐M., Teubner, A., Burden, S.

Volltext

A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer von Morgan, R.D., Jayson, G.C., Banerjee, S., Clamp, A.R., Lyon, A.R., Ryder, W.D., Hutson, R., Mescallado, N., Orbegoso Aguilar, C., Taylor, S., Tugwood, J., Hall, M., Dive, C., Rustin, G.J.S.

Volltext

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium von Goranova, T, Ennis, D, Piskorz, A M, Macintyre, G, Lewsley, L A, Stobo, J, Wilson, C, Kay, D, Glasspool, R M, Lockley, M, Brockbank, E, Montes, A, Walther, A, Sundar, S, Edmondson, R, Hall, G D, Clamp, A, Gourley, C, Hall, M, Fotopoulou, C, Gabra, H, Freeman, S, Moore, L, Jimenez-Linan, M, Paul, J, Brenton, J D, McNeish, I A

Volltext

The clinical potential of antiangiogenic fragments of extracellular matrix proteins von CLAMP, A. R, JAYSON, G. C

Volltext

Development of ex vivo phenotypic assays to enable precision medicine in the context of high grade serous ovarian cancer von Nelson, L, Tighe, A, Clamp, A, Edmondson, R, Jayson, G, Taylor, S

Volltext

Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3 von Lorusso, D., Coleman, R.L., Oza, A.M., Aghajanian, C., Oaknin, A., Dean, A., Colombo, N., Weberpals, J.I., Clamp, A.R., Scambia, G., Leary, A., Holloway, R.W., Amenedo Gancedo, M., Fong, P.C., Goh, J.C., O’Malley, D.M., Banerjee, S., Goble, S., Cameron, T., Ledermann, J.A.

Volltext

A novel discharge pathway for patients with advanced cancer requiring home parenteral nutrition von Bond, A., Teubner, A., Taylor, M., Willbraham, L., Gillespie, L., Farrer, K., McMahon, M., Leahy, G., Abraham, A., Soop, M., Clamp, A. R., Hasan, J., Mitchell, C., Jayson, G. C., Lal, S.

Volltext

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian t... von Clamp, A.R., McNeish, I.A., Dean, A., Gallardo-Rincon, D., Kim, J.-W., O’Donnell, D.M., Hook, J., Blagden, S., Brenton, J.D., Naik, R., Perren, T.J., Sundar, S., Cook, A.D., James, E.C., Gabra, H., Lord, R., Hall, M., Dark, G., Kaplan, R.S., Ledermann, J.A.

Volltext

Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma von DANSON, S, LORIGAN, P, ARANCE, A, CLAMP, A, RANSON, M, HODGETTS, J, LOMAX, L, ASHCROFT, L, THATCHER, N, MIDDLETON, M. R

Volltext

Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytot... von Mitchell, C.L., O'Connor, J.P.B., Jackson, A., Parker, G.J.M., Roberts, C., Watson, Y., Cheung, S., Davies, K., Buonaccorsi, G.A., Clamp, A.R., Hasan, J., Byrd, L., Backen, A., Dive, C., Jayson, G.C.

Volltext

Heparan sulphate synthetic and editing enzymes in ovarian cancer von BACKEN, A. C, COLE, C. L, LAU, S. C, CLAMP, A. R, MCVEY, R, GALLAGHER, J. T, JAYSON, G. C

Volltext

Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK von Khoja, L, Nolan, K, Mekki, R, Milani, A, Mescallado, N, Ashcroft, L, Hasan, J, Edmondson, R, Winter-Roach, B, Kitchener, H.C, Mould, T, Hutson, R, Hall, G, Clamp, A.R, Perren, T, Ledermann, J, Jayson, G.C

Volltext

Accessing cancer services in North West England: the Chinese population von Conway, A.M., Clamp, A.R., Hasan, J., Goonetilleke, D., Shore, K., Wong, L.M.J., Wong, J., Jayson, G.

Volltext